Heart medicine side effects
Pro Research Analysisby 
Searched over 200M research papers
Heart Medicine Side Effects: A Comprehensive Overview
Cardiac Side Effects of Cancer Chemotherapy
Cancer chemotherapy, particularly with combination, adjuvant, and targeted therapies, has expanded the spectrum of cardiac side effects. Anthracyclines, for instance, cause cardiac toxicity through oxidative stress and apoptosis, detectable via advanced imaging techniques and biomarkers like troponin and NT-proBNP . High doses of alkylating agents such as cyclophosphamide and ifosfamide can lead to reversible heart failure and life-threatening arrhythmias . Antimetabolites like 5-fluorouracil and capecitabine can induce myocardial ischemia, especially in patients with pre-existing coronary artery disease (CAD) . Targeted therapies, including tyrosine kinase inhibitors (TKIs) like trastuzumab, can cause heart failure or asymptomatic left ventricular (LV) dysfunction . Other agents like bevacizumab may lead to severe hypertension and venous thromboembolism .
Cardiovascular Adverse Effects of Herbal Medicines
Herbal medicines, though popular, pose significant cardiovascular risks. Serious adverse effects include arrhythmias, arteritis, chest pain, congestive heart failure, hypertension, hypotension, myocardial infarction, and even death . These issues often stem from toxic ingredients, adulteration, contamination, and herb-drug interactions. Notable herbs with repeated adverse reports include aconite, ephedra, and licorice .
Cardiovascular Risks of Antipsychotic Medications
Atypical antipsychotic (AA) medications like risperidone and olanzapine are associated with increased cardiovascular disease risk due to side effects such as obesity, insulin resistance, dyslipidemia, and hypertension . Studies in mice have shown that these drugs alter the cardiac proteomic signature, affecting mitochondrial function and oxidative phosphorylation, which may contribute to adverse cardiac outcomes .
Beta-Blockers in Heart Failure: Genuine vs. Spurious Side Effects
Beta-blockers, essential in heart failure management, often have side effects that are not significantly more common than those experienced with a placebo. For instance, dizziness, diarrhea, and hyperglycemia are frequently reported but occur similarly in placebo groups . Genuine side effects predominantly due to beta-blockers include bradycardia and intermittent claudication . Interestingly, beta-blockers may reduce the incidence of depression and insomnia .
Side Effects of Nitrates in Heart Failure and Acute Coronary Syndromes
Nitrates, used for chest pain and pulmonary congestion relief, commonly cause headaches and hypotension, with varying incidence across different conditions . Severe hypotension or death can occur when nitrates are used in specific scenarios, such as acute inferior myocardial infarction with right ventricular dysfunction or with phosphodiesterase-5 inhibitors .
Cardiovascular Side Effects of Immunotherapies in Cancer
Immune checkpoint inhibitors (ICIs) and adoptive cell transfer (ACT) therapies for cancer are linked to significant cardiovascular side effects. ICIs are associated with myocarditis, cardiac failure, acute coronary syndrome, and pericarditis, while ACTs are linked to tachyarrhythmia, cardiac arrest, and cardiorenal events . These therapies exhibit unique side effect profiles, with ICIs causing autoimmune-related adverse reactions and ACTs leading to cytokine-release-related issues .
Cardiac Effects of Antidepressant Drugs
Tricyclic antidepressants (TCAs) have notable cardiovascular effects due to their anticholinergic and quinidine-like properties, causing heart rate increases, postural hypotension, and QT interval prolongation . In contrast, fluvoxamine, a selective serotonin reuptake inhibitor, has minimal cardiac effects, only slightly slowing the heart rate .
Conclusion
Heart medications, ranging from cancer chemotherapies to herbal remedies and psychiatric drugs, carry a spectrum of cardiovascular side effects. Understanding these risks is crucial for optimizing patient care and mitigating adverse outcomes. Continuous monitoring, patient education, and interdisciplinary collaboration are essential strategies in managing these side effects effectively.
Sources and full results
Most relevant research papers on this topic